161 related articles for article (PubMed ID: 21913872)
1. Genetic association studies in drug-induced liver injury.
Daly AK; Day CP
Drug Metab Rev; 2012 Feb; 44(1):116-26. PubMed ID: 21913872
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced liver injury: past, present and future.
Daly AK
Pharmacogenomics; 2010 May; 11(5):607-11. PubMed ID: 20415545
[TBL] [Abstract][Full Text] [Related]
3. Genetic basis of drug-induced liver injury: present and future.
Urban TJ; Daly AK; Aithal GP
Semin Liver Dis; 2014 May; 34(2):123-33. PubMed ID: 24879978
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis.
Huang YS; Chern HD; Su WJ; Wu JC; Lai SL; Yang SY; Chang FY; Lee SD
Hepatology; 2002 Apr; 35(4):883-9. PubMed ID: 11915035
[TBL] [Abstract][Full Text] [Related]
5. Genetic association studies in drug-induced liver injury.
Daly AK; Day CP
Semin Liver Dis; 2009 Nov; 29(4):400-11. PubMed ID: 19826974
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress.
Boelsterli UA; Lee KK
J Gastroenterol Hepatol; 2014 Apr; 29(4):678-87. PubMed ID: 24783247
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of N-acetyltransferase 2 slow acetylators to antituberculosis drug-induced liver injury: a meta-analysis.
Shi J; Xie M; Wang J; Xu Y; Liu X
Pharmacogenomics; 2015 Dec; 16(18):2083-97. PubMed ID: 26616266
[TBL] [Abstract][Full Text] [Related]
8. Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India.
Gupta VH; Amarapurkar DN; Singh M; Sasi P; Joshi JM; Baijal R; Ramegowda PH; Amarapurkar AD; Joshi K; Wangikar PP
J Gastroenterol Hepatol; 2013 Aug; 28(8):1368-74. PubMed ID: 23875638
[TBL] [Abstract][Full Text] [Related]
9. The association between HLA-DQB1 polymorphism and antituberculosis drug-induced liver injury: a Case-Control Study.
Chen R; Zhang Y; Tang S; Lv X; Wu S; Sun F; Xia Y; Zhan SY
J Clin Pharm Ther; 2015 Feb; 40(1):110-5. PubMed ID: 25250564
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.
Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K
Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096
[TBL] [Abstract][Full Text] [Related]
11. Are Polymorphisms in Genes Relevant to Drug Disposition Predictors of Susceptibility to Drug-Induced Liver Injury?
Daly AK
Pharm Res; 2017 Aug; 34(8):1564-1569. PubMed ID: 28028769
[TBL] [Abstract][Full Text] [Related]
12. Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug Regimens.
Nicoletti P; Devarbhavi H; Goel A; Venkatesan R; Eapen CE; Grove JI; Zafer S; Bjornsson E; Lucena MI; Andrade RJ; Pirmohamed M; Wadelius M; Larrey D; Maitland-van der Zee AH; Ibanez L; Watkins PB; Daly AK; Aithal GP
Clin Pharmacol Ther; 2021 Apr; 109(4):1125-1135. PubMed ID: 33135175
[TBL] [Abstract][Full Text] [Related]
13. Liver injury caused by drugs: an update.
Stirnimann G; Kessebohm K; Lauterburg B
Swiss Med Wkly; 2010; 140():w13080. PubMed ID: 20927685
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen genetic risk factors of drug-induced liver toxicology.
Grove JI; Aithal GP
Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):395-409. PubMed ID: 25491399
[TBL] [Abstract][Full Text] [Related]
15. NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis.
Wang PY; Xie SY; Hao Q; Zhang C; Jiang BF
Int J Tuberc Lung Dis; 2012 May; 16(5):589-95. PubMed ID: 22409928
[TBL] [Abstract][Full Text] [Related]
16. Using genome-wide association studies to identify genes important in serious adverse drug reactions.
Daly AK
Annu Rev Pharmacol Toxicol; 2012; 52():21-35. PubMed ID: 21819236
[TBL] [Abstract][Full Text] [Related]
17. N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.
Mishra S; Daschakraborty S; Shukla P; Kapoor P; Aggarwal R
Natl Med J India; 2013; 26(5):260-5. PubMed ID: 25017831
[TBL] [Abstract][Full Text] [Related]
18. NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis.
Lee SW; Chung LS; Huang HH; Chuang TY; Liou YH; Wu LS
Int J Tuberc Lung Dis; 2010 May; 14(5):622-6. PubMed ID: 20392357
[TBL] [Abstract][Full Text] [Related]
19. The NAT2 tag SNP rs1495741 correlates with the susceptibility of antituberculosis drug-induced hepatotoxicity.
Ho HT; Wang TH; Hsiong CH; Perng WC; Wang NC; Huang TY; Jong YJ; Lu PL; Hu OY
Pharmacogenet Genomics; 2013 Apr; 23(4):200-7. PubMed ID: 23407048
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population.
Leiro-Fernandez V; Valverde D; Vázquez-Gallardo R; Constenla L; Fernández-Villar A
Pharmacogenomics; 2010 Sep; 11(9):1205-6; author reply 1207-8. PubMed ID: 20860460
[No Abstract] [Full Text] [Related]
[Next] [New Search]
